Masafumi Kurosumi

Aryl hydrocarbon receptor suppresses intestinal carcinogenesis in <i>Apc</i> ^{<i>Min</i> /+} mice with natural ligands

Kaname Kawajiri, Yasuhito Kobayashi, Fumiaki Ohtake et al. · Proceedings of the National Academy of Sciences · 2009 · 264 citations · Full text

Medicine, Molecular Biology, Oncology +17

Isolation and characterization of a new human breast cancer cell line, KPL-4, expressing the Erb B family receptors and interleukin-6

Junichi Kurebayashi, Takemi Otsuki, Catherine Tang et al. · British Journal of Cancer · 1999 · 199 citations · Full text

Medicine, Cell Biology, Oncology +14

The ubiquitin ligase CHIP acts as an upstream regulator of oncogenic pathways

Masashi Kajiro, Ryuichi Hirota, Yuka Nakajima et al. · Nature Cell Biology · 2009 · 156 citations

Medicine, Cancer Biology, Molecular Biology +15

Phase II study of preoperative sequential FEC and docetaxel predicts of pathological response and disease free survival

Masakazu Toi, Seigo Nakamura, Katsumasa Kuroi et al. · Breast Cancer Research and Treatment · 2007 · 113 citations

Medicine, Oncology, Oncologic Surgery +8

Development of automated brightfield double In Situ hybridization (BDISH) application for HER2 gene and chromosome 17 centromere (CEN 17) for breast carcinomas and an assay performance comparison to manual dual color HER2 fluorescence In Situ hybridization (FISH)

Hiroaki Nitta, Beatrice Hauss‐Wegrzyniak, Megan Lehrkamp et al. · Diagnostic Pathology · 2008 · 111 citations · Full text

Medicine, Molecular Biology, Oncology +17